386 related articles for article (PubMed ID: 9616767)
1. Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis.
Hafler DA; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Fukaura H
Ann N Y Acad Sci; 1997 Dec; 835():120-31. PubMed ID: 9616767
[TBL] [Abstract][Full Text] [Related]
2. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
J Clin Invest; 1996 Jul; 98(1):70-7. PubMed ID: 8690806
[TBL] [Abstract][Full Text] [Related]
3. Antigen-specific TGF-beta1 secretion with bovine myelin oral tolerization in multiple sclerosis.
Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
Ann N Y Acad Sci; 1996 Feb; 778():251-7. PubMed ID: 8610978
[TBL] [Abstract][Full Text] [Related]
4. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis.
Inobe J; Slavin AJ; Komagata Y; Chen Y; Liu L; Weiner HL
Eur J Immunol; 1998 Sep; 28(9):2780-90. PubMed ID: 9754565
[TBL] [Abstract][Full Text] [Related]
5. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
Link J
Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
[TBL] [Abstract][Full Text] [Related]
7. Pulse cyclophosphamide plus methylprednisolone induces myelin-antigen-specific IL-4-secreting T cells in multiple sclerosis patients.
Takashima H; Smith DR; Fukaura H; Khoury SJ; Hafler DA; Weiner HL
Clin Immunol Immunopathol; 1998 Jul; 88(1):28-34. PubMed ID: 9683547
[TBL] [Abstract][Full Text] [Related]
8. Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis.
Windhagen A; Anderson DE; Carrizosa A; Balashov K; Weiner HL; Hafler DA
J Neuroimmunol; 1998 Nov; 91(1-2):1-9. PubMed ID: 9846813
[TBL] [Abstract][Full Text] [Related]
9. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression.
Chen Y; Inobe J; Weiner HL
J Immunol; 1995 Jul; 155(2):910-6. PubMed ID: 7541826
[TBL] [Abstract][Full Text] [Related]
10. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis.
Rohowsky-Kochan C; Molinaro D; Cook SD
Mult Scler; 2000 Apr; 6(2):69-77. PubMed ID: 10773850
[TBL] [Abstract][Full Text] [Related]
11. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.
Hellings N; Barée M; Verhoeven C; D'hooghe MB; Medaer R; Bernard CC; Raus J; Stinissen P
J Neurosci Res; 2001 Feb; 63(3):290-302. PubMed ID: 11170179
[TBL] [Abstract][Full Text] [Related]
12. Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice.
Santos LM; al-Sabbagh A; Londono A; Weiner HL
Cell Immunol; 1994 Sep; 157(2):439-47. PubMed ID: 7520838
[TBL] [Abstract][Full Text] [Related]
13. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.
Miller A; Lider O; Roberts AB; Sporn MB; Weiner HL
Proc Natl Acad Sci U S A; 1992 Jan; 89(1):421-5. PubMed ID: 1370356
[TBL] [Abstract][Full Text] [Related]
14. Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: demonstration of T cell anergy.
Jewell SD; Gienapp IE; Cox KL; Whitacre CC
Immunol Cell Biol; 1998 Feb; 76(1):74-82. PubMed ID: 9553779
[TBL] [Abstract][Full Text] [Related]
15. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.
Bai XF; Shi FD; Xiao BG; Li HL; van der Meide PH; Link H
J Neuroimmunol; 1997 Dec; 80(1-2):65-75. PubMed ID: 9413260
[TBL] [Abstract][Full Text] [Related]
16. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.
Khoury SJ; Hancock WW; Weiner HL
J Exp Med; 1992 Nov; 176(5):1355-64. PubMed ID: 1383385
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta 1 suppresses autoantigen-induced expression of pro-inflammatory cytokines but not of interleukin-10 in multiple sclerosis and myasthenia gravis.
Link J; He B; Navikas V; Palasik W; Fredrikson S; Söderström M; Link H
J Neuroimmunol; 1995 Apr; 58(1):21-35. PubMed ID: 7537278
[TBL] [Abstract][Full Text] [Related]
18. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA
J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366
[TBL] [Abstract][Full Text] [Related]
19. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells.
Weiner HL
Immunol Rev; 2001 Aug; 182():207-14. PubMed ID: 11722636
[TBL] [Abstract][Full Text] [Related]
20. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals.
Tejada-Simon MV; Hong J; Rivera VM; Zhang JZ
Eur J Immunol; 2001 Mar; 31(3):907-17. PubMed ID: 11241296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
